From theheart.org on Medscape

Coverage from the

International Society of Heart and Lung Transplantation (ISHLT) 2017 Scientific Sessions

April 05 - 08, 2017; San Diego, California

April 05 - 08, 2017 San Diego, California
  • ISHLT Donor-Derived DNA Predicts Lung Transplant Rejection Before any clinical signs of graft failure are evident in patients who undergo lung transplant, experimental research suggests that donor-derived cell-free DNA could help predict a poor outcome.
  • ISHLT Less Bleeding, Clotting With HeartMate 3 LVAD A 6-month secondary analysis shows fewer hemocompatibility-related problems with the newer device. A patient-focused scoring system for these outcomes was proposed.
  • ISHLT HVAD Leads to Fewer Hemorrhagic Strokes Than HeartMate II This study 'will hammer home the importance of managing blood pressure,' said one expert, but 'a 15% stroke rate is probably still unacceptable in our patient population,' said another.

Conference News

Popular News from ISHLT 2016

©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.